Cyrelle Ornella, M.S.; Kim, J.-J.; Cho, E.; Cho, M.; Hwang, T.-H.
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials. Vaccines 2024, 12, 1010.
https://doi.org/10.3390/vaccines12091010
AMA Style
Cyrelle Ornella MS, Kim J-J, Cho E, Cho M, Hwang T-H.
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials. Vaccines. 2024; 12(9):1010.
https://doi.org/10.3390/vaccines12091010
Chicago/Turabian Style
Cyrelle Ornella, Mefotse Saha, Jae-Joon Kim, Euna Cho, Mong Cho, and Tae-Ho Hwang.
2024. "Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials" Vaccines 12, no. 9: 1010.
https://doi.org/10.3390/vaccines12091010
APA Style
Cyrelle Ornella, M. S., Kim, J.-J., Cho, E., Cho, M., & Hwang, T.-H.
(2024). Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials. Vaccines, 12(9), 1010.
https://doi.org/10.3390/vaccines12091010